Biopreparedness: Developing vaccines for an eradicated disease

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The accidental discovery of smallpox vials at the National Institutes of Health earlier this year quickly attracted the attention of the health and security communities. Smallpox was officially eradicated decades ago, and is only supposed to exist in two carefully guarded labs - and the National Institutes of Health isn't one of them This interview focuses on a biotech company that has spent the last 10 years developing a vaccine against what has so far been a non-existent disease. It discusses possible avenues for the re-emergence of smallpox, including the impact of developments in synthetic biology, and it gives an inside view on the biodefence industry and its unusual business model.

Cite

CITATION STYLE

APA

Lentzos, F., & Cohn, J. T. (2014, November 11). Biopreparedness: Developing vaccines for an eradicated disease. BioSocieties. Palgrave Macmillan. https://doi.org/10.1057/biosoc.2014.38

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free